Number of the records: 1  

Liečba hepatocelulárneho karcinómu v hodnotení HTA (Health Technology Assessment)

  1. SYS0162900
    LBL
      
    00000naa^^22^^^^^^^^450
    005
      
    20200330090132.0
    100
      
    $a 20200214d2019 m y0sloy0103 ba
    101
    0-
    $a slo $d eng $d slo
    102
      
    $a SK
    200
    1-
    $a Liečba hepatocelulárneho karcinómu v hodnotení HTA (Health Technology Assessment) $d Treatment of hepatocellular carcinoma in HTA evaluation $f Branislav Obšitník $z eng
    320
      
    $a Bibliogr. odkazy
    320
      
    $a Res. angl., slov.
    463
    -1
    $1 001 sllk_un_cat*0162731 $1 011 $a 1337-9836 $1 200 1 $a Trendy v hepatológii $v Roč. 11, č. 2 (2019), s. 11-16 $1 210 $a Bratislava $c Pharmedcons $d 2019 $1 215 $a s. 3-23
    510
    1-
    $a Treatment of hepatocellular carcinoma in HTA evaluation $z eng
    606
    1-
    $3 sllk_un_auth*d006528 $a karcinóm hepatocelulárny $x farmakoterapia $2 mesh
    606
    1-
    $3 sllk_un_auth*d013673 $a hodnotenie zdravotníckych technológií $2 mesh
    606
    1-
    $3 sllk_un_auth*d005062 $a Európska únia $2 mesh
    606
    2-
    $3 sllk_un_auth*d000077157 $a sorafenib $2 mesh
    610
    2-
    $a HTA (health technology assessment)
    610
    2-
    $a EUnetHTA (The European Network of Health Technology Assessment)
    610
    2-
    $a štúdia RESORCE
    610
    2-
    $a regorafenib
    700
    -1
    $3 sllk_un_auth*p0068072 $a Obšitník $b Branislav $p Oddelenie brachyterapie, Klinika radiačnej onkológie SZU a OÚSA, Bratislava $4 070
    801
    -0
    $a SK $b BA006 $c 20200214 $g AACR2
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.